BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18395561)

  • 1. Screening for neuroblastoma: a resurrected idea?
    Maris JM; Woods WG
    Lancet; 2008 Apr; 371(9619):1142-3. PubMed ID: 18395561
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study.
    Hiyama E; Iehara T; Sugimoto T; Fukuzawa M; Hayashi Y; Sasaki F; Sugiyama M; Kondo S; Yoneda A; Yamaoka H; Tajiri T; Akazawa K; Ohtaki M
    Lancet; 2008 Apr; 371(9619):1173-80. PubMed ID: 18395578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for neuroblastoma in children.
    Morris JK
    J Med Screen; 2002; 9(2):56. PubMed ID: 12133921
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening of infants and mortality due to neuroblastoma.
    Woods WG; Gao RN; Shuster JJ; Robison LL; Bernstein M; Weitzman S; Bunin G; Levy I; Brossard J; Dougherty G; Tuchman M; Lemieux B
    N Engl J Med; 2002 Apr; 346(14):1041-6. PubMed ID: 11932470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroblastoma Early Detection Model Project. Background and results].
    Schilling FH
    Kinderkrankenschwester; 2002 Jul; 21(7):295-6. PubMed ID: 14606374
    [No Abstract]   [Full Text] [Related]  

  • 6. Poor prognosis neuroblastoma: is screening the answer?
    Craft AW; Parker L
    Br J Cancer Suppl; 1992 Aug; 18():S96-101. PubMed ID: 1503935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of mass screening for neuroblastoma in Sapporo, Japan.
    Takeda T; Nishi M; Shimada M; Nakadate H; Hatae Y; Naito H; Hanai J; Kawai T; Takasugi N
    Prog Clin Biol Res; 1991; 366():595-601. PubMed ID: 2068178
    [No Abstract]   [Full Text] [Related]  

  • 8. Improvement in prognosis of neuroblastoma through mass population screening.
    Naito H; Sasaki M; Yamashiro K; Takeda T; Takasugi N; Uchino J; Hata Y
    J Pediatr Surg; 1990 Feb; 25(2):245-8. PubMed ID: 2303994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for neuroblastoma: progress and pitfalls.
    Ross JA; Davies SM
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):189-94. PubMed ID: 10067819
    [No Abstract]   [Full Text] [Related]  

  • 10. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society].
    Sawada T; Nagahara N; Ohi R; Yamamoto K; Okabe I; Hanawa Y; Hashizume K; Matsui I; Ohkawa H; Tunoda A
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2319-26. PubMed ID: 2260868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population-based study of the usefulness of screening for neuroblastoma.
    Woods WG; Tuchman M; Robison LL; Bernstein M; Leclerc JM; Brisson LC; Brossard J; Hill G; Shuster J; Luepker R; Byrne T; Weitzman S; Bunin G; Lemieux B
    Lancet; 1996 Dec 21-28; 348(9043):1682-7. PubMed ID: 8973429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroblastoma screening: arguments from retrospective analysis of three German neuroblastoma trials.
    Berthold F; Hunneman DH; Käser H; Harms D; Bertram U; Erttmann R; Schilling FH; Treuner J; Zieschang J
    Am J Pediatr Hematol Oncol; 1991; 13(1):8-13. PubMed ID: 1903028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of 598 cases of neuroblastoma (NB) detected by screening and changes in the age distribution and incidence of NB patients after mass screening in infants in Japan. NB Screening Study Group.
    Sawada T; Shikata T; Matsumura T; Kawakatsu H; Sugimoto T
    Prog Clin Biol Res; 1994; 385():371-5. PubMed ID: 7972233
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for neuroblastoma (NB) in North America: the Quebec Project.
    Woods WG; Lemieux B; Leclerc JM; Bernstein ML; Brisson L; Brossard J; Brodeur GM; Look AT; Robison LL; Shuster JJ
    Prog Clin Biol Res; 1994; 385():377-82. PubMed ID: 7972234
    [No Abstract]   [Full Text] [Related]  

  • 15. Mass screening of neuroblastoma in Sapporo City, Japan.
    Nishi M; Miyake H; Takeda T; Kikuchi Y; Hanai J; Yonemori H; Takasugi N
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):327-31. PubMed ID: 1456398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroblastoma screening in early life.
    Collins MH
    N Engl J Med; 2002 Sep; 347(11):852-4; author reply 852-4. PubMed ID: 12227370
    [No Abstract]   [Full Text] [Related]  

  • 17. Biological analysis of neuroblastoma in mass screened negative cases.
    Ishimoto K; Kiyokawa N; Fujita H; Yabuta K; Ohya T; Miyano T; Shinohara T; Sera Y
    Prog Clin Biol Res; 1991; 366():603-8. PubMed ID: 2068179
    [No Abstract]   [Full Text] [Related]  

  • 18. Japanese mass screening for neuroblastoma.
    Kudo K; Arai Y; Kondo Y
    Lancet; 1998 Oct; 352(9136):1316. PubMed ID: 9788492
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Neuroblastoma screening test may do more harm than good.
    Schilling FH
    J Natl Cancer Inst; 1997 Jul; 89(14):1078-9. PubMed ID: 9230892
    [No Abstract]   [Full Text] [Related]  

  • 20. Past and future of neuroblastoma screening in Japan.
    Sawada T
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):320-6. PubMed ID: 1456397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.